IL6 and cancer: Constitutive activation of STAT3 (pSTAT3), a hallmark of many cancers, is driven by persistent exposure to cytokines such as IL-6, IL-10, and oncostatin M, leading to continuous phosphorylation and nuclear translocation of STAT3.